GSK Canada Receives Approval For Shingrix Zoster Vaccine In Prefilled Syringe
GSK Canada today announced the approval of Shingrix (GSK's Recombinant Zoster Vaccine or RZV) in a prefilled syringe. This new presentation removes the need to reconstitute separate vials prior to administration,
GSK got approval to sell its shingles vaccine in a easier form — it comes ready to use instead of needing to mix powder and liquid first. This makes the vaccine simpler for doctors to give, which could help more people get protected.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.